
Phillip Minar
Professor of Clinical-Affiliate · University of Cincinnati Medical Center Inc.
Credentials: · · ·
History
Research
Review · Alimentary Pharmacology & Therapeutics · 2015 · 89 citations
Clinical Pharmacology & Therapeutics · 2021 · Last of 14 authors · Corresponding · 70 citations
Development of Infliximab Target Concentrations During Induction in Pediatric Crohn Disease Patients
Journal of Pediatric Gastroenterology and Nutrition · 2019 · Last of 6 authors · Corresponding · 61 citations

25 papers

18 papers

16 papers
- JH
15 papers

13 papers

9 papers · 7 as a fellow

8 papers

7 papers
Grants
- 1995–2030
Pediatric Gastroenterology and Nutrition Training Grant
National Institute of Diabetes and Digestive and Kidney Diseases · T32
Contact PI · $522.4K · Cincinnati Childrens Hosp Med Ctr
- 2022–2027
National Institute of Diabetes and Digestive and Kidney Diseases · R01
Contact PI · $3.5M · Cincinnati Childrens Hosp Med Ctr
- 2018–2021
National Institute of Diabetes and Digestive and Kidney Diseases · R03
Contact PI · $238.5K · Cincinnati Childrens Hosp Med Ctr
- 2015–2019
Therapeutic Monitoring and Targeting of Neutrophil Activation in Pediatric IBD
National Institute of Diabetes and Digestive and Kidney Diseases · K23
Contact PI · $734.3K · Cincinnati Childrens Hosp Med Ctr
Clinical trials
- 2023–2027
Precise Infliximab Exposure and Pharmacodynamic Control
Principal investigator · Recruiting · Phase 2, Phase 3
Children's Hospital Medical Center, Cincinnati
- 2021–2024
Principal investigator · Terminated · Phase 2, Phase 3
Children's Hospital Medical Center, Cincinnati
- 2019–2023
Precision Crohn's Disease Management Utilizing Predictive Protein Panels (ENvISION)
Principal investigator · Completed
Children's Hospital Medical Center, Cincinnati



